05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
The Seventh Circuit Court of Appeals recently ruled that the American with Disabilities Act (“ADA”...
Read More >
The Town of Smithtown is considering the adoption of a local law that would allow residential uses a...
Read More >
Skanska USA Building, Inc. v. J.D. Long Masonry, Inc., No. 1:16-cv-00933, 2019 BL 336852, (D. Md. Se...
Read More >
Antitrust FAQs for Merging Parties - What modifications have the FTC and DOJ made for transactions ...
Read More >
Employees and job applicants in New Jersey who are lawful medical cannabis users can hold their head...
Read More >
State and local governments are taking aggressive actions to contain the COVID-19 virus by limiting ...
Read More >